Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

SBFM Sunshine Biopharma Inc.
$1.17 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy SBFM stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 5.8M
Enterprise value -2551543
Trailing PE 0.22598872
Forward PE 0.006006006
PEG Ratio -0.0028323919573333
Enterprise to EBITDA 0.56
Enterprise to revenue -0.068
Price to book MRQ 0.22603127
Price to sales TTM 0.15773161

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 37.3M
EBITDA -4559393
Diluted EPS TTM 5.31
Total Cash (MRQ) 9.3M
Current ratio (MRQ) 4.205
Operating Cash Flow (TTM) -7126728

SBFM trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent SBFM News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.